French Registry of CMR Late Gadolinium Enhancement in Myocarditis
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Myocarditis Acute. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Retrospective French Registry of Cardiovascular Magnetic Resonance Late Gadolinium Enhancement in Patients With Myocarditis
Overview
Acute myocarditis is a major cause of death in young adults and carries substantial morbidity, including a significant risk of progression to dilated cardiomyopathy. Current diagnostic and therapeutic strategies remain poorly defined, making risk stratification crucial to enable personalized treatments and reduce mortality and major cardiovascular events.
Primary outcome measures
- All-cause mortality [Time frame: From enrollment to the end of follow up at 10 years]
Secondary outcome measures (4)
- All-cause death [Time frame: From enrollment to the end of follow up at 10 years]
- Heart transplantation [Time frame: From enrollment to the end of follow up at 10 years]
- Ventricular arrhythmia [Time frame: From enrollment to the end of follow up at 10 years]
- Hospitalisation for acute heart failure [Time frame: From enrollment to the end of follow up at 10 years]
Eligibility criteria
Inclusion criteria
- Age ≥ 18 years
- Ability to provide informed non-opposition
- AM diagnosis confirmed using CMR, fulfilling the modified Lake Louise diagnostic criteria
Exclusion criteria
1\. Patients unable to provide informed non-opposition.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07394543 · APHP251399